A new concept of kinetic modules in biochemical networks could revolutionize the understanding of how these networks function ...

A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Neurons deep in the brain not only help to initiate movement—they also actively suppress it, and with astonishing precision.